How Does the Human Microbiome Influence Oral and Gut Brain Axes
Human Microbiome Hub
Your Complete Guide to Microbes, Immunity, Digestion & the Oral–Gut–Brain Axis
The human microbiome is not just a trend — it is one of the most important discoveries in modern biology. Rather than a collection of isolated microbes, the microbiome functions as a living regulatory system that continuously interacts with the digestive, immune, metabolic, and nervous systems.
Trillions of microorganisms living in and on the human body shape:
-
digestion and nutrient absorption
-
gut lining integrity and mucosal defense
-
immune balance and inflammation
-
metabolic regulation
-
oral health and microbial migration
-
mood, stress response, and cognition
-
long-term disease risk
This Human Microbiome Cluster brings together five core articles written by Ali Rıza Akın, designed to guide readers from foundational understanding to emerging innovations in microbiome science.
Reduced levels of Akkermansia muciniphila are among the most consistent microbial patterns associated with inflammation, metabolic dysfunction, and gut-barrier weakening. For readers seeking a more profound, science-based exploration of this keystone concept and how it fits into overall microbiome balance, the Akkermansia Microbiome Guide provides a focused continuation:

Among the microbial species that help regulate this delicate environment, Akkermansia muciniphila plays a unique role in maintaining gut lining integrity and supporting mucosal health. Its interaction with the mucus layer has been closely associated with metabolic balance and barrier function, making it one of the most studied next-generation probiotics. For a deeper understanding of its mechanisms and clinical relevance, explore our detailed guide to the benefits of Akkermansia muciniphila.
Start Here: What Is the Human Microbiome?
What Is the Human Microbiome? A Complete Guide to Microbes, Immunity & Digestion
This pillar article explains:
-
what the human microbiome is
-
where microbes live (gut, mouth, skin, lungs, reproductive tract)
-
how they support digestion, immunity, and gut barrier health
-
how SCFAs, mucin, and microbial diversity influence overall health
-
foundational references such as the Human Microbiome Project
Use this as the primary educational entry point for new readers.
The Mouth Comes First: Oral Microbiota & Gut Health
Oral Microbiota & Gut Health: How the Mouth Shapes the Entire Microbiome
This article covers:
-
what the oral microbiota is
-
how over one billion oral bacteria migrate into the gut daily
-
how oral dysbiosis can trigger gut dysbiosis and inflammation
-
why the oral–gut axis is critical for digestion and immunity
-
why chewable formulations differ from capsules
Ideal for understanding oral–gut connections and the relevance of delivery format.
Mind–Gut Link: The Gut–Brain Axis
The Gut–Brain Axis: How Microbes Influence Mood, Stress, Appetite & Mental Well-Being
This blog explains:
-
what the gut–brain axis is
-
how microbes affect serotonin, dopamine, GABA, and stress response
-
how dysbiosis contributes to anxiety, cravings, poor sleep, and low mood
-
the interplay between oral microbes, gut microbes, and the vagus nerve
-
how polyphenols, SCFAs, and gut-lining integrity all contribute to mental health
Great for connecting microbiome support to mood, stress & appetite.
The gut microbiome does not act in isolation; it actively participates in metabolic signaling pathways that influence appetite, glucose regulation, and energy balance. One of the most important of these pathways involves GLP-1, a hormone regulated indirectly by microbial activity and short-chain fatty acid production. To understand how gut bacteria shape this signaling system, see our comprehensive breakdown of the microbiome-GLP-1 connection.
Origins: Microbiome Development From Birth to Adulthood
Microbiome Development From Birth to Adulthood: How Early Life Shapes Lifetime Health
This article explores:
-
how microbiota colonization begins at birth
-
differences between vaginal birth vs. C-section
-
the role of breastfeeding, HMOs (2’-FL), and early diet
-
how early-life disruptions (antibiotics, environment, feeding) shape lifelong immunity and metabolic risk
-
how microbiome development continues through childhood, adolescence, and aging
Perfect for parent education, early-life support positioning, and explaining why prevention starts early.
What’s Next: Microbiome Innovations & Future Science
Microbiome Innovations & The Future of Microbial Science: What’s Coming Next
This future-facing article covers:
-
next-generation probiotics (Akkermansia, Christensenella, C. butyricum)
-
mucin-layer repair and gut barrier therapeutics
-
oral–gut-focused interventions
-
SCFA biology and precision microbial therapies
-
microbiome-based precision nutrition and AI-guided personalization
-
microbiome innovations in sustainability and environmental health
FAQ:
1. What foods help support a healthier microbiome?
A healthier microbiome is usually supported by a varied, fiber-rich diet, not by a single food. Medical sources consistently point to whole grains, beans, lentils, fruits, vegetables, and other plant foods because they provide the fibers and prebiotics gut microbes use. Naturally fermented foods such as yogurt, kefir, kimchi, and sauerkraut can also help support a more favorable microbial environment.
Scientific Reference:
https://my.clevelandclinic.org/health/body/25201-gut-microbiome
https://my.clevelandclinic.org/health/diseases/dysbiosis
https://www.health.harvard.edu/blog/fermented-foods-for-better-gut-health-201805161607
https://www.health.harvard.edu/blog/how-and-why-to-fit-more-fiber-and-fermented-food-into-your-meals-202404263036
2. Can antibiotics disrupt the microbiome, and what helps afterward?
Yes. Antibiotics can reduce both beneficial and harmful bacteria, which is one reason digestion may feel different during or after a course. Many people recover after temporary exposure, but some may benefit from additional support such as prebiotics, probiotics, and a fiber-rich diet. NIH notes that certain probiotics used with antibiotics may help reduce the risk of C. difficile-associated diarrhea, although the best strains and timing can vary.
Scientific Reference:
https://my.clevelandclinic.org/health/body/25201-gut-microbiome
https://www.nccih.nih.gov/health/probiotics-usefulness-and-safety
https://my.clevelandclinic.org/health/diseases/dysbiosis
As research continues to evolve, it is becoming increasingly clear that specific microbial species and metabolic pathways act as central regulators of human health. From the structural role of bacteria such as Akkermansia muciniphila in maintaining gut barrier integrity to their influence on signaling pathways, such as GLP-1, the microbiome represents a dynamic control system rather than a passive ecosystem. Exploring these connections in depth provides a clearer roadmap for targeted microbiome support and long-term metabolic resilience.
About the Author
All articles in this cluster are written by:
Ali Rıza Akın
Microbiome Scientist, Author & Founder of Next-Microbiome
Ali Rıza Akın is a microbiome scientist with nearly 30 years of experience in biotechnology and translational research, specializing in human-associated microbial ecosystems and their role in long-term health.
His scientific focus includes:
-
gut mucosal immunity and epithelial barrier integrity
-
oral–gut microbial transmission pathways
-
short-chain fatty acid (SCFA) signaling and host metabolism
-
immune–microbiome communication
-
next-generation probiotic strain discovery and formulation
Akın is the discoverer of Christensenella californii, a novel human-associated microbial species linked to metabolic and mucosal health, and has conducted extensive research on emerging keystone microbes, including Akkermansia muciniphila and Clostridium butyricum.
His work bridges fundamental microbiome science with real-world translational applications, applying systems biology principles to understand how microbial ecosystems interact with the gut lining, immune system, nervous system, and metabolic organs as an integrated network.
Ali Rıza Akın is the author of Bakterin Kadar Yaşa: İçimizdeki Evren and a contributing author to Bacterial Therapy of Cancer: Methods and Protocols (Springer). He is the Founder of Next-Microbiome, where he develops evidence-driven synbiotic formulations designed to support gut barrier function and the oral–gut–brain axis.